Sharescart Research Club logo ×
Screener Research Unlisted Startup Funding New IPO New

  • Home
  • /
  • Shilpa Medicare
Join Channel
Consolidated Standalone

Shilpa Medicare

₹506.9 8.1 | 1.6%

Market Cap ₹4957 Cr.

Stock P/E -6565.4

P/B 2.2

Current Price ₹506.9

Book Value ₹ 234.1

Face Value 1

52W High ₹561.2

Dividend Yield 0%

52W Low ₹ 228.3

Edit Ratio

Shilpa Medicare Research see more...

Overview Inc. Year: 1987Industry: Pharmaceuticals & Drugs

Shilpa Medicare Ltd is engaged in the commercial enterprise of producing of bulk drugs or API and intermediates, and wind power generation. The Company's segments comprises Bulk Drug/Intermediates and Energy. It gives 3a 7b Dihydroxy. The Company deals with APIs, Intermediates, Formulations, New Drug Delivery Systems, Peptides/Biotech products and Speciality Chemicals. The Company resources oncology/non-oncology APIs and intermediates. Its oncology API products include Anastrozole, Axitinib, Azacitidine, Abiraterone Acetate, Bicalutamide, Bortezomib, Busulphan, Cabazitaxel Amorphous, Capecitabine, Carboplatin, Cladribine, Clofarabine, Zoledronic acid, Vismodegib, Pemetrexed DiPotassium Nonahydrate, Cyclophosphamide Monohydrate and Cytarabine. It also gives AntiRetroVirals. Its non-oncology API products include Perfenidone, PrucaloprideSuccinate, Sildenafil Citrate, Ursodeoxycholic acid, Acebrophylline, Echothiophate, Nifedipine, and Dimethyl Fumarate.

Read More..

Shilpa Medicare Share Price

New

₹ | |

Volume
Price

Quarterly Price

Quarterly Monthly
Show Value Show %

Peer Comparison

Shilpa Medicare Quarterly Results

#(Fig in Cr.) Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023
Net Sales 295 272 341 261 263 262 264 260 313 286
Other Income 1 5 5 8 4 3 2 2 2 2
Total Income 297 278 346 269 267 265 266 262 315 289
Total Expenditure 242 227 267 241 251 231 225 212 253 221
Operating Profit 54 51 79 29 17 34 40 50 62 68
Interest 12 10 9 10 13 18 18 18 23 26
Depreciation 19 21 22 22 23 24 26 27 28 27
Exceptional Income / Expenses 9 0 -0 0 0 0 0 0 0 0
Profit Before Tax 33 20 47 -3 -20 -8 -3 5 11 15
Provision for Tax 12 10 17 -6 -4 -1 4 2 8 9
Profit After Tax 21 10 31 3 -16 -7 -7 3 3 6
Adjustments -1 -1 -1 -2 -2 0 -1 -2 -2 -1
Profit After Adjustments 20 10 30 1 -19 -7 -8 1 2 5
Adjusted Earnings Per Share 2.4 1.1 3.4 0.1 -2.2 -0.8 -0.9 0.1 0.2 0.5

Shilpa Medicare Profit & Loss

#(Fig in Cr.) Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 TTM
Net Sales 371 571 614 716 779 789 733 908 901 1146 1050 1123
Other Income 6 9 7 11 29 33 16 22 40 21 31 8
Total Income 377 580 621 728 808 821 749 930 941 1166 1082 1132
Total Expenditure 303 455 487 556 618 638 579 693 729 948 962 911
Operating Profit 75 125 133 171 191 184 170 237 212 218 120 220
Interest 2 4 4 4 3 3 4 5 22 41 59 85
Depreciation 15 23 21 23 31 37 42 44 54 80 95 108
Exceptional Income / Expenses -0 -3 -0 -2 -5 0 20 0 61 9 0 0
Profit Before Tax 57 95 108 140 146 137 136 188 195 102 -38 28
Provision for Tax 10 20 35 36 42 34 26 33 49 42 -7 23
Profit After Tax 47 75 73 105 104 103 110 155 146 61 -31 5
Adjustments -0 1 1 4 3 2 3 2 2 0 -2 -6
Profit After Adjustments 47 76 74 108 108 105 112 156 148 61 -32 0
Adjusted Earnings Per Share 6.4 10.3 9.6 14.1 13.4 12.9 13.8 19.2 18.1 7 -3.7 -0.1

Growth Rates

# 1 Year 3 Year 5 Year 10 Year
Sales CAGR -8% 5% 6% 11%
Operating Profit CAGR -45% -20% -8% 5%
PAT CAGR -151% NAN% NAN% NAN%
# 1 Year 3 Year 5 Year 10 Year
Share Price CAGR 97% 4% 6% 8%
ROE Average -2% 4% 7% 12%
ROCE Average 1% 6% 8% 13%

Shilpa Medicare Balance Sheet

#(Fig in Cr.) Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Shareholder's Funds 320 396 547 639 987 1085 1198 1329 1479 1822 1783
Minority's Interest 9 10 14 2 -3 -5 -8 -8 -11 -11 -9
Borrowings 70 67 102 0 143 68 81 165 474 354 289
Other Non-Current Liabilities 28 37 52 67 109 85 86 92 87 99 56
Total Current Liabilities 124 167 189 222 237 266 253 411 587 612 783
Total Liabilities 551 678 905 931 1472 1499 1610 1989 2632 2875 2902
Fixed Assets 181 294 316 393 492 534 558 650 1111 1342 1368
Other Non-Current Assets 159 149 261 183 250 293 507 715 619 646 766
Total Current Assets 212 234 328 354 730 672 545 624 862 887 768
Total Assets 551 678 905 931 1472 1499 1610 1989 2632 2875 2902

Shilpa Medicare Cash Flow

#(Fig in Cr.) Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Opening Cash & Cash Equivalents 2 17 9 4 7 100 74 34 44 123 25
Cash Flow from Operating Activities 44 70 69 129 37 45 147 124 47 105 226
Cash Flow from Investing Activities -95 -49 -195 -109 -262 -9 -196 -290 -404 -285 -278
Cash Flow from Financing Activities 66 -28 136 -20 313 -61 10 176 436 83 46
Net Cash Inflow / Outflow 15 -7 10 -0 88 -25 -39 10 79 -98 -7
Closing Cash & Cash Equivalent 17 9 18 6 100 74 34 44 123 25 19

Shilpa Medicare Ratios

# Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Earnings Per Share (Rs) 6.43 10.29 9.56 14.05 13.43 12.91 13.77 19.15 18.13 6.99 -3.74
CEPS(Rs) 8.54 13.37 12.2 16.59 16.86 17.18 18.59 24.33 24.55 16.17 7.44
DPS(Rs) 0.65 0.5 0.55 0.6 0.6 0.7 1 1.1 1.1 1.1 0
Book NAV/Share(Rs) 43.52 53.86 70.92 82.91 123.17 133.09 146.89 163.06 181.37 209.93 205.44
Core EBITDA Margin(%) 18.14 20.05 20.41 22.15 20.62 19.11 21 23.63 19.05 17.21 8.41
EBIT Margin(%) 15.66 17.11 18.06 19.98 19.09 17.62 19 21.21 24.07 12.52 1.94
Pre Tax Margin(%) 15.06 16.5 17.41 19.44 18.69 17.28 18.5 20.71 21.65 8.93 -3.65
PAT Margin (%) 12.54 12.99 11.72 14.5 13.33 13 14.93 17.02 16.22 5.29 -2.94
Cash Profit Margin (%) 16.6 17 15.18 17.71 17.24 17.7 20.67 21.85 22.21 12.26 6.15
ROA(%) 9.64 12.23 9.18 11.41 8.69 6.92 7.04 8.59 6.33 2.2 -1.07
ROE(%) 15.93 20.98 15.4 17.66 12.85 9.93 9.59 12.23 10.41 3.67 -1.71
ROCE(%) 15.04 20.48 17.9 19.69 15.28 11.13 10.45 12.38 10.73 5.94 0.8
Receivable days 39.7 34.62 43.99 52.26 69 90.2 105.51 90.56 97.28 98.75 123.51
Inventory Days 68.31 62.33 74.84 66.97 75.49 87.32 93.66 83.24 113.34 109.68 117.32
Payable days 92.11 84.03 95.15 90.7 107.17 110.56 130.97 113.86 113.98 106 127.45
PER(x) 12.73 20.07 51.88 30.47 47.36 36.02 24.71 12.77 18.42 56.83 0
Price/Book(x) 1.88 3.83 6.99 5.16 5.16 3.49 2.32 1.5 1.84 1.89 1.12
Dividend Yield(%) 0.53 0.24 0.11 0.14 0.09 0.15 0.29 0.45 0.33 0.28 0
EV/Net Sales(x) 1.93 2.85 6.51 4.72 6.72 4.95 3.92 2.58 3.82 3.57 2.63
EV/Core EBITDA(x) 9.6 13.01 29.95 19.73 27.42 21.26 16.94 9.88 16.25 18.78 23.11
Net Sales Growth(%) 16.7 53.88 7.42 16.72 8.76 1.24 -7.03 23.8 -0.75 27.12 -8.33
EBIT Growth(%) 6.51 67.01 13.05 28.96 3.7 -6.82 -0.05 38.22 12.62 -33.88 -85.8
PAT Growth(%) 15.45 58.33 -3.36 44.22 -0.28 -1.52 6.45 41.15 -5.41 -58.56 -151.03
EPS Growth(%) 14.8 59.84 -7.07 47.02 -4.45 -3.85 6.67 39.1 -5.36 -61.45 -153.54
Debt/Equity(x) 0.41 0.3 0.34 0.14 0.24 0.18 0.16 0.29 0.57 0.37 0.45
Current Ratio(x) 1.71 1.4 1.73 1.6 3.08 2.53 2.15 1.52 1.47 1.45 0.98
Quick Ratio(x) 1.12 0.69 1.07 1.01 2.28 1.82 1.41 0.97 0.9 0.88 0.57
Interest Cover(x) 26.13 28.09 27.63 36.69 47.73 52.39 37.91 42.26 9.92 3.48 0.35
Total Debt/Mcap(x) 0.22 0.08 0.05 0.03 0.05 0.05 0.07 0.2 0.31 0.2 0.4

Shilpa Medicare Shareholding Pattern

# Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024
Promoter 50.01 50.01 50.01 50.01 50.01 50.01 50.01 50.01 50.01 50.01
FII 14.59 14.41 14.41 10.98 11.85 10.26 10.26 8.6 8.52 5.69
DII 2.87 1.93 1.99 5.24 4.1 4.03 0.37 0.41 0.06 1.69
Public 32.54 33.65 33.59 33.77 34.04 35.71 39.37 40.99 41.41 42.62
Others 0 0 0 0 0 0 0 0 0 0
Total 100 100 100 100 100 100 100 100 100 100

Pros

  • Company has reduced debt.
  • Company is almost debt free.

Cons

  • Company has a low return on equity of 4% over the last 3 years.
  • Debtor days have increased from 106 to 127.45days.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Shilpa Medicare News

IPO

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

You May Also Know About

Unlisted Shares Pre-IPO Shares ESOP Shares Delisted Shares

Please Login!

Click to Login
OR
Get free Account

Error!